During the past decade, Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly" are "Low-grade Serous Fallopian Tube Cancer" (1 trials), "Low-grade Serous Ovarian Cancer" (1 trials), "Low-grade Serous Peritoneal Cancer" (1 trials), "Neoplasms" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly" in a lesser frequency.

Most popular intervention types in "Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Bintrafusp alfa" (1 trials), "MEK162, MEK inhibitor; oral" (1 trials), "PLD" (1 trials) and "Physician's choice chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly" are 3 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".